| Sign In to gain access to subscriptions and/or personal tools. |
Surrogate Markers for Atherosclerosis in Overweight Subjects With Atherogenic Dyslipidemia: The GEMS ProjectDepartment of Internal Medicine, CHUV-University Hospital, Lausanne, Switzerland
Institute of Social Medicine and Epidemiology, CHUV-University Hospital, Lausanne, Switzerland
Division of Clinical Pathophysiology, CHUV-University Hospital, Lausanne, Switzerland
Department of Internal Medicine, CHUV-University Hospital, Lausanne, Switzerland
Medical Outpatient Clinic, CHUV-University Hospital, Lausanne, Switzerland
Department of Internal Medicine, CHUV-University Hospital, Lausanne, Switzerland
Medical Genetics, Genetic Research, GlaxoSmithKline, Collegeville Pennsylvania
Division of Clinical Pathophysiology, CHUV-University Hospital, Lausanne, Switzerland
Division of Angiology, CHUV-University Hospital, Lausanne, Switzerland
Department of Internal Medicine, CHUV-University Hospital, Lausanne, Switzerland, Gerard.Waeber{at}chuv.ch
Metabolic syndrome is a constellation of major risk factors for cardiovascular disease. In affected individuals with this syndrome, the independent contribution of low high-density lipoprotein—cholesterol and increased triglyceride levels to the development of atherosclerosis remains to be clarified. We assessed the relationship between these 2 parameters and several surrogate markers for atherosclerosis. One hundred and twenty overweight cases, defined as having high-density lipoprotein—cholesterol (
This version was published on August
1, 2008 Angiology, Vol. 59, No. 4,
484-492 (2008) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 age- and gender-specific percentile in general population) and high triglyceride values (
75 percentile) were compared with 120 discordant overweight controls defined on lipid values (high-density lipoprotein—cholesterol